SRZN
Surrozen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.76
+0.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 95.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.22x
- Price / sales
- 23.24x
- Price / cash flow
- -7.70x
Enterprise value
- Enterprise value
- $171.8M
- EV / sales
- 14.92x
- EV / EBITDA
- -0.52x
- EV / EBIT
- -3.87x
- Market cap
- $267.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026